An exchange-traded fund providing exposure to U.S. pharmaceutical companies, holding a portfolio of drug manufacturers selected and weighted using a quantitative model. The fund is designed to track the Dynamic Pharmaceuticals Intellidex Index, which evaluates companies based on factors such as pric...
5 members of Congress have disclosed 9 trades in Invesco Pharmaceuticals ETF (PJP), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 6 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-07-19 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2015-08-08 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2011-03-05 | JAMES B. RENACCI | buy | $650.43 |
| 2010-11-08 | JAMES B. RENACCI | buy | $1,231.68 |
| 2010-04-08 | JAMES B. RENACCI | buy | $792.56 |
| 2009-05-08 | Lamar Smith | sell | $1,476.40 |
| 2009-05-06 | Lynn Jenkins | sell | $1K – $15K |
| 2008-07-03 | SHELLEY BERKLEY | sell | — |
| 2008-07-03 | SHELLEY BERKLEY | sell | — |